Mypross Pharmaceuticals Private Limited

Mypross Pharmaceuticals Private Limited - food and beverages in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U24304DL2018PTC329656 Incorporated 20 February 2018 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company food and beverages MSME · Micro
Revenue · FY 2023
₹1.44 Lakh
▼ 68% YoY
Net loss · FY 2023
₹2.47 Lakh
Net margin -171.8%
EBITDA · FY 2023
-₹2.23 Lakh
EBITDA margin -154.7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹3 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
3
As per MCA filings
Last financials
Mar 2023
Balance sheet date

About Mypross Pharmaceuticals Private Limited

Data last updated:

Mypross Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the manufacturing segment of the food and beverages sector. It was incorporated on 20 February 2018 and has been in existence for over 8 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24304DL2018PTC329656.

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors including Md Safi Ahamad and Kavita Kumari.

Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at U – 128 Uppar G/F Kh No. – 343 & 344 U – Block Subhash Park Uttam Nagar, New Delhi, Delhi, India – 110059.

As per the financials filed for FY 2023, the company reported a revenue of ₹1.44 Lakh, a decline of 68% compared to the previous year. For the same year it recorded a net loss of ₹2.47 Lakh (net margin -171.8%) and EBITDA of -₹2.23 Lakh (EBITDA margin -154.7%). Revenue has declined at a compounded annual rate (CAGR) of 59% over three years.

Mypross Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-11-0044115).

Company details

CIN U24304DL2018PTC329656
Registration Number 329656
Incorporation Date 20 February 2018
ROC Delhi
Listing Status Unlisted
Company Status Active
MSME Classification Micro
Udyam Registration UDYAM-DL-11-0044115
Key People
Md Safi Ahamad Director Kavita Kumari Director Mithilesh Kumar Director

Recognitions & Rankings of Mypross Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-DL-11-0044115

Contact details

Mypross Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.

  • Email
  • Registered Address
    U – 128 Uppar G/F Kh No. – 343 & 344 U – Block Subhash Park Uttam Nagar, New Delhi, Delhi, India – 110059
  • Industry
    Food And Beverages, Manufacturing, Artificial Fibres

To see the full contact details of Mypross Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Mypross Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Mypross Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Mypross Pharmaceuticals Private Limited, buy the company report.

Financials of Mypross Pharmaceuticals Private Limited

FY 2023 filings available

Mypross Pharmaceuticals Private Limited reported revenue of ₹1.44 Lakh (down 68% YoY) for FY 2023.

Revenue · FY 2023
₹1.44 Lakh ▼ 68%
Net loss · FY 2023
₹2.47 Lakh margin -171.8%
EBITDA · FY 2023
-₹2.23 Lakh margin -154.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 68%
3 years · compounded
▼ 59%
EBITDA CAGR growth
1 year
▲ 69%
3 years · compounded
▼ 85%

Revenue has declined at a compounded annual rate (CAGR) of 59% over three years, including a 68% fall in the latest year. EBITDA rose 69% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹2.23 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹2.47 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin-154.7%
Net Profit Margin-171.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Mypross Pharmaceuticals Private Limited, buy the company report.

Board of directors of Mypross Pharmaceuticals Private Limited

Mypross Pharmaceuticals has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Md Safi Ahamad
Also directs: Delbert Pharmaceuticals Private Limited
Director20 Feb 20188 Years 8 MonthsCurrent
Kavita KumariDirector02 Jun 20188 Years 5 MonthsCurrent
Mithilesh KumarDirector20 Feb 20188 Years 8 MonthsCurrent
View all directors

Peer comparison

Mypross Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Clievo Pharmaceuticals Private Limited₹1.45 Lakh (FY 2024)-66.0%Ranchi, Jharkhand, India
Mishka Pharmaceuticals Private Limited₹1.45 Lakh (FY 2023)-76.0%Indore, Madhya Pradesh, India
Mypross Pharmaceuticals Private Limitedthis company₹1.44 Lakh (FY 2023)-₹2.47 Lakh-171.8%-68.0%New Delhi, Delhi, India
Alan Pharmaceuticals Private Limited₹1.44 Lakh (FY 2021)-80.0%Silchar, Assam, India
Leonkare Pharmaceuticals Private Limited₹1.43 Lakh (FY 2025)-98.0%Kalapahar, Guwahati, Kamrup, Assam, India
Doctsmedi Pharmaceuticals Private Limited₹1.41 Lakh (FY 2024)-69.0%Lucknow, Uttar Pradesh, India

To see the full peer comparison of Mypross Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Mypross Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Mypross Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Mypross Pharmaceuticals Private Limited has 6 board changes on record since 2018: 3 appointments and 3 cessations. The latest: Kavita Kumari ceased to be Additional Director on 30 Sep 2019.

AGM
Mypross Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Filing
Mypross Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi.
Ceased
Kavita Kumari ceased to be Additional Director.
Appointed
Kavita Kumari was appointed as Director.
Ceased
Gouri Kumari ceased to be Additional Director.
Ceased
Ruhul Afsar ceased to be Additional Director.
Appointed
Md Safi Ahamad was appointed as Director.
Appointed
Mithilesh Kumar was appointed as Director.
Incorporation
20 Feb 2018
Mypross Pharmaceuticals Private Limited was registered on 20 Feb 2018 with Roc Delhi & aged 8 years 8 months as per MCA records.

Frequently asked questions

Mypross Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in manufacturing, within the food and beverages industry. It was incorporated on 20 February 2018 (8+ years old) and is registered under CIN U24304DL2018PTC329656.

Mypross Pharmaceuticals has 3 current directors:

The latest financial statements of Mypross Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2018 are in the company report.

The CIN (Corporate Identification Number) of Mypross Pharmaceuticals is U24304DL2018PTC329656. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Mypross Pharmaceuticals was incorporated on 20 February 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Mypross Pharmaceuticals by revenue are Clievo Pharmaceuticals Private Limited, Mishka Pharmaceuticals Private Limited, Alan Pharmaceuticals Private Limited, Leonkare Pharmaceuticals Private Limited, Doctsmedi Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).

Kavita Kumari ceased to be Additional Director on 30 Sep 2019. Kavita Kumari was appointed as Director on 02 Jun 2018. Gouri Kumari ceased to be Additional Director on 21 May 2018. Mypross Pharmaceuticals has 6 board changes on record in total.

Yes, Mypross Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-11-0044115).

The registered office of Mypross Pharmaceuticals is at U – 128 Uppar GF Kh No. – 343 & 344 U – Block Subhash Park Uttam Nagar, New Delhi, Delhi, India – 110059.

Mypross Pharmaceuticals operates in the food and beverages industry, in the manufacturing segment.

Mypross Pharmaceuticals can be reached at its registered office: U – 128 Uppar GF Kh No. – 343 & 344 U – Block Subhash Park Uttam Nagar, New Delhi, Delhi, India – 110059.